RHYTHM PHARMACEUTICALS, INC. - COM (RYTM)

Historical Portfolio Holders from Q4 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
67.7 M
Holdings value Q1 2024
$2.93 B
Value change Q1 2024
+$57.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
159
Number of buys Q1 2024
82
Number of sells Q1 2024
-73
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
76243J105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 67.7 M $2.93 B +$57.1 M $43.33 164
2023 Q4 66.4 M $3.05 B -$32.7 M $45.97 165
2023 Q3 68.1 M $1.56 B +$52.4 M $22.93 144
2023 Q2 66 M $1.09 B +$94.9 M $16.49 114
2023 Q1 56.4 M $1.01 B -$50.4 M $17.84 123
2022 Q4 62.2 M $1.81 B +$85.3 M $29.12 114
2022 Q3 59.4 M $1.44 B +$425 M $24.50 95
2022 Q2 44.3 M $184 M -$10.5 M $4.15 75
2022 Q1 48.4 M $557 M +$5.26 M $11.52 98
2021 Q4 48.3 M $482 M -$577 K $9.98 89
2021 Q3 47.7 M $623 M +$5.07 M $13.06 92
2021 Q2 47.3 M $902 M -$4.69 M $19.58 98
2021 Q1 47.6 M $1.01 B +$148 M $21.27 120
2020 Q4 40.5 M $1.2 B +$38.7 M $29.73 113
2020 Q3 39.2 M $850 M -$43.7 M $21.67 111
2020 Q2 41.2 M $919 M +$11.8 M $22.30 85
2020 Q1 40.8 M $621 M -$33.7 M $15.22 77
2019 Q4 40 M $918 M +$205 M $22.96 86
2019 Q3 31.2 M $674 M +$64.8 M $21.59 81
2019 Q2 28.2 M $620 M +$8.6 M $22.00 79
2019 Q1 30.9 M $846 M -$21.9 M $27.41 83
2018 Q4 31.7 M $851 M +$12.8 M $26.88 71
2018 Q3 30.3 M $885 M -$10.3 M $29.17 73
2018 Q2 31 M $966 M +$213 M $31.26 83
2018 Q1 20.4 M $406 M -$5.86 M $19.90 52
2017 Q4 21.6 M $628 M +$507 M $29.06 64